Gainers

  • PHAXIAM Therapeutics PHXM stock rose 36.4% to $0.6 during Thursday's pre-market session. The market value of their outstanding shares is at $36.4 million.
  • GRI Bio GRI stock increased by 14.8% to $3.18. The market value of their outstanding shares is at $9.2 million.
  • vTv Therapeutics VTVT shares increased by 13.21% to $0.76. The market value of their outstanding shares is at $61.9 million.
  • Vistagen Therapeutics VTGN stock rose 12.01% to $7.88. The company's market cap stands at $62.9 million. As per the news, the Q1 earnings report came out today.
  • Senti Biosciences SNTI shares increased by 10.13% to $0.9. The company's market cap stands at $39.5 million.
  • T2 Biosystems TTOO stock increased by 10.1% to $0.38. The market value of their outstanding shares is at $109.4 million. As per the news, the Q2 earnings report came out 3 days ago.

Losers

  • Galera Therapeutics GRTX shares fell 82.9% to $0.38 during Thursday's pre-market session. The company's market cap stands at $16.4 million.
  • Organogenesis Hldgs ORGO stock decreased by 35.99% to $2.17. The company's market cap stands at $284.8 million. The company's, Q2 earnings came out yesterday.
  • Matinas BioPharma Hldgs MTNB stock decreased by 24.31% to $0.25. The market value of their outstanding shares is at $55.0 million. The company's, Q2 earnings came out yesterday.
  • 180 Life Sciences ATNF stock decreased by 21.81% to $0.66. The market value of their outstanding shares is at $3.5 million.
  • Renovaro Biosciences RENB stock decreased by 16.78% to $1.29. The market value of their outstanding shares is at $82.1 million.
  • Certara CERT stock fell 13.51% to $15.5. The market value of their outstanding shares is at $2.4 billion. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!